Inside the Tulane Cancer Center Spring 2003 Newsletter Accolades: Faculty Honors and Awards

Gerald S. Berenson, M.D. Diane A. Blake, Ph.D. Arnold Brody, Ph.D. Joan Cheng, M.D. Melanie Ehrlich, Ph.D. Kelly Jackson, M.S. Frank E Jones, Ph.D.

Erich K. Lang, M.D. Marilyn M. Li, M.D. Laura S. Levy, Ph.D. Alan M. Miller, Ph.D., M.D. Timothy Pearman, Ph.D. Janet Schmid, M.D. Raju Thomas, M.D.

Study Section Participation

Gerald S. Berenson, M.D.

• Past president of the Society of Geriatric Cardiology
• Principal Investigator, Evolution of C/V Risk With Normal Aging, National Institute on Aging, $2.5 million (May 2000 - August 2005)

Diane A. Blake, Ph.D.

• Published:
  • Blake RC II, Delehanty JB, Khosraviani M, Yu H, Jones RM, Blake DA: Allosteric binding properties of a monoclonal antibody and its Fab fragment. Biochemistry, 42:497-598, 2003.
• Presented:
  • Immunoassay for Serum Cadmium: A New Tool to Assess Risk for Pancreatic Cancer at the 225th ACS National Meeting, New Orleans, March 23-27, 2003.
• Received the Woman of Achievement Award 2002 from the International Biographical Center, Cambridge, England.
• Elected Co-Director of the Tulane Interdisciplinary Graduate Program in Molecular and Cellular Biology, 2003-2006.
• Principal Investigator, In-Line Uranium Immunosensor, Department of Energy, NABIR Program, $315,792 (direct costs), $92,534 (indirect costs) (September 2002 - September 2004).

Arnold R. Brody, Ph.D.

• Published:
  • Warshamana GS, Pociask DA, Fisher KJ, Liu JY, Sime PJ, Brody AR: Titration of non-replicating adenovirus as a vector for transducing active TGF-beta 1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice. Intl J Exp Path, 83: 1-19, 2002.
  • Warshamana GS, Pociask DA, Sime PJ, Schwartz DA, Brody AR: Susceptibility to asbestos-induced and TGF-beta1-induced fibroproliferative lung disease in two strains of mice. American Journal of Respiratory Cell and Molecular Biology, 27: 705-713, 2002.
• Principal Investigator, TGF-beta in Interstitial Disease, NIH, $900,000 (September 2002 - August 2006)

Joan Cheng, M.D.

• Authored a book chapter:
  Cancer of the Uterine Cervix, in Conn's Current Therapy, 55th edition, Ed. by Robert E. Rakel and Edward T. Bope, W.B. Saunders Publishing Co., Chapter 16, 1162-1166, 2003.
  
  
• Presented Cancer in Pregnancy: What the Ob/Gyn Should Know, Ob/Gyn Grand Rounds, Tulane University School of Medicine, October 2002.

Melanie Ehrlich, Ph.D.

• Published:
  • Ehrlich M: DNA hypomethylation, cancer, the ICF syndrome, and chromosomal rearrangements. Journal of Nutrition, 132:2424S-2429S, 2002.
  • Ehrlich M: DNA methylation in cancer: too much, but also too little. (Invited review) Oncogene, 21:5400-5413, 2002.
  • Ehrlich M, Jiang G, Fiala E, Dome J, Yu M, Long T, Youn B, Sohn O, Widschwendter M, Tomlinson G, Chintagumpala M, Champagne M, Parham D, Liang G, Malik K, Laird P: Hypomethylation and hypermethylation of DNA in Wilms' tumors. Oncogene, 21:6694-6702, 2002.
• Presented:
  • Histone Modification of D4Z4 Hypomethylation and Chromosome Instability in the ICF Syndrome and Cancer, FSH Society Workshop - Chromatin Structure and the FSHD Syndrome, Baltimore, Maryland, October 2002.
  • member of the FSH (Fascioscapulohumeral Muscular Dystrophy) Society, 2000 - present, and the Pediatric Oncology Group, 1998 - present.

Kelly E. Jackson, M.S.

• Presented at the round table discussion on breast cancer, Louisiana Breast Cancer Task Force, September 2002.
• Selected as one of 40 outstanding men and women in the local area to be named members of this year's CityBusiness "Power Generation."

Frank E. Jones, Ph.D.

• Recently received a National Cancer Coalition grant of $60,000 for his research into the role of a growth factor receptor biologically important in both breast and prostate cancers.
• Published:
  • Li L, Cleary S, Long W, Mandarano MA, Birchmeier C, Jones FE: The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene, 21:4900-4907, 2002.
• Mentor on two Department of Defense Breast Cancer Research Program Predoctoral Traineeship Awards for proposals (Both grants are for three years with budgets of $90,000.) submitted by:
  • Weiwen Long, Department of Structural and Cellular Biology - ErbB4 overexpression as an antagonist of ErbB2/HER2/Neu induced human breast cancer cell proliferation
  • Gregory Vidal, Department of Structural and Cellular Biology - ErbB4, suppressor of ErbB2-induced oncogenesis in a novel mouse model of breast cancer

Erich K. Lang, M.D.

• Published:
  • Lang EK, Macchia R, Thomas R, Ruiz-Deya G, Watson RA, Richter F, Irwin R, Marberger M, Mydlo J, Lechner G, Cho K, Gayle B: Computerized tomography tailored for assessment of microscopic hematuria. Journal of Urology, 167:547-554, 2002.
• Presented:
  • Macchia RJ, Lang EK, Thomas R, Ruiz-Deya G, Gayle B, Watson R: CT findings of early papillary necrosis and changes indicating progressive disease, American Urological Association meeting, Orlando, Florida, 2002.
  • Lang EK, Thomas R, Macchia RJ, Gayle B, Richter F, Watson RA: CT findings of early papillary necrosis and changes indicating progressive disease, European Congress of Radiology, Vienna, Austria, 2002.
  • Johnson H, Lang EK, Thomas R, Watson RA, Davis R, Richter R, Marberger M: Tailored CT for assessment of microscopic hematuria (assessment of 350 consecutive cases), American Roentgen Society, Atlanta, Georgia, 2002.

Laura S. Levy, Ph.D.

• Published:
  • Rulli K, Lenz J, Levy LS: Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 MuLV. Journal of Virology, 76:2363-2374, 2002.
• Presented:
  • Pathogenic Mechanisms in Animal Models of Virus-Induced Lymphoma, Oncology Grand Rounds, LSU Health Sciences Center, July 2002.
  • Small Animal Models of Virus-Induced Lymphoma, Center for Gene Therapy, Tulane University Health Sciences Center, August 2002.
  • Genetic Variation and Pathogenesis by Feline Leukemia Virus, Workshop on Animal Virus Models for Human Cancer, Gaithersburg, Maryland, October 2002.
• Principal Investigator:
  • Growth Regulation of SAIDS-Associated Lymphomas, Ladies Leukemia League, $35,000 total direct costs (June 2002 - May 2003).
  • Pathobiology of SAIDS-Associated Lymphoma, National Cancer Institute (NIH), $875,000 total direct costs (July 2002 - June 2007).
  • Selective Forces Operative in FeLV Infection, National Cancer Institute (NIH), $800,414 total direct costs (March 2000 - February 2005).

Marilyn M. Li, M.D.

• Published:
  • Rivera A, Li M, Bertran G, Krause J: Trisomy 4 as the sole cytogenetic abnormality in Waldenstrom's macroglobulinemia. Cancer Genetics and Cytogenetics, 133(2):172-3, 2002.
• Gave the following presentations at the 52nd Annual Meeting of The American Society of Human Genetics in Baltimore, Maryland, October 2002:
  • Li MM, Jackson KE, Kim KC, Andersson H: Dysmorphic features, extra chromosome material and multi-color FISH.
  • Kim KC, Jackson KE, Pridjian G, Mao R, Li MM: Prenatal diagnosis of a trisomy 21 fetus with an unusual familial t(15;21) translocation.
  • Van Brunt J, Mao R, Faucheaux A, Li MM: Molecular characterization of mosaic tetraploidy in chorionic villi tissue from a missed abortion.
• Member, American Society of Human Genetics, Southwest Oncology Group Cytogenetics Committee, Children's Oncology Group, and Board of Directors of the North American Association of Chinese Medical Geneticists; founding member, American College of Medical Genetics.
• Co-Principal Investigator with Melanie Ehrlich, Ph.D., FSHD Syndrome: DNA Repeats, Methylation & Chromatin, NIH, $375,000 (October 2001 - September 2004).

Alan M. Miller, Ph.D., M.D.

• recently appointed Associate Senior Vice President for Health Sciences

Timothy Pearman, Ph.D.

• Presented:
  • Psychological Adjustment and Issues in Solid Organ Transplantation, Multi-Organ Transplant Group, Tulane University Health Sciences Center, January 2003.
  • Gynecologic Malignancies: Review of Research and Case Presentation, Ob/Gyn Grand Rounds, Tulane University Health Sciences Center, January 2003.
  • Gynecologic Cancer and Psychosocial Morbidity, Society of Gynecologic Oncology Annual Meeting, New Orleans, January 2003.
  • NIH Consensus Conference on Symptom Management: Pain, Depression and Fatigue. Summary and Thoughts on the State of the Science, Hem/Onc Grand Rounds, Tulane University Health Sciences Center, February 2003.

Janet Schmid, M.D.

• Published:
  • Schmid JL, McCullough J, Burger SR, Hubel A: Noncryopreserved bone marrow storage in STM-Sav, an infusible-grade cell storage solution. Cell Preservation Technology, 1(1), 2002.

Raju Thomas, M.D.

• recently attended along with Rodney Davis, M.D., a training seminar in robotic prostatectomy for prostate cancer at Henry Ford Hospital's Vattikuti Urology Institute in Detroit, Michigan.

---

Study Section Participation
As Study Section participants, several Tulane Cancer Center faculty members help to influence the direction of research. Listed below are Study Section appointments held by some Tulane Cancer Center faculty:

• Krishna C. Agrawal, Ph.D.
  • NIH, NCI Experimental Therapeutics I Study Section, 2002 - 2005
    
  • Merit Review Subcommittee for Oncology, Department of Veterans Affairs, 2000-2003
• Arnold R. Brody, Ph.D.
  • Chair, National Heart, Lung, and Blood Institute Special Emphasis Panel - Molecular Targets and Interventions in Pulmonary Fibrosis
  • University of California, Tobacco-Related Diseases Research Program, Pulmonary Disease Review Committee
  • American Heart Association Peer Review Study Group, Lung, Resuscitation and Respiration
• Tyler J. Curiel, M.D.
  • NCI P30 Program, Subcommittee C, Basic and Preclinical Sciences, Ad-hoc reviewer
• Srikanta Dash, Ph.D.
  • NIH Experimental Virology Study Section (Ad-hoc reviewer)
  • Special Emphasis Review Panel on Drug Development for Hepatitis C
• Samir El-Dahr, M.D.
  • NIH General Medicine B (GMB) Study Section, 2002-2006
• Prescott Deininger, Ph.D.
  • DOD Breast Cancer Study Section
  • NIH Human Genome Study Section
• Erik K. Flemington, Ph.D.
  • NIH Experimental Virology Study Section
• Mitchell Friedman, M.D.
  • Special Emphasis Review Panel (NHLBI), Asthma Clinical Research Network
  • Special Emphasis Review Panel (NHLBI), COPD Clinical Research Network
  • NIH Advisory Board of Pain Therapy and Palliative Care (NIHPPC)
• Carolyn C. Johnson, Ph.D.
  • DOD, Prostate Cancer Study Section, Chair (since 1998)
  • DOD, Breast Cancer Study Section, Chair (since 1993)
  • Division of Transplantation, DHHS, Extramural Research on Organ Procurement, Chair (since 1999)
• Laura S. Levy, Ph.D.
  • NIH Virology Study Section, 1996-2000, 2001-2005
• Arthur J. Lustig, Ph.D.
  • NSF Study Panel in Eukaryotic Genetics
• Ken Muneoka, Ph.D.
  • NIH Cell Development and Function 4 (CDF4), 2002-2003
• Larry S. Webber, Ph.D.
  • NIH EDC-1, Epidemiology and Disease Control (just completed term as four-year permanent member; currently ad-hoc reviewer)
• Roy S. Weiner, M.D.
  • NIH, T-Cell Depletion Data and Safety Monitoring Board
  • NIH, Basic Research on Mesenchymal Stem Cell Biology Special Emphasis Panel
  • NCI, Overcoming Barriers to Early Phase Clinical Trials
  • NHLBI, Research in Stem Cell Biology and Cell Based Therapies for Heart, Lung, Blood and Sleep Disorders Special Emphasis Panel

Return to the Spring 2003 "Inside the Tulane Cancer Center" newsletter.

---

Tulane Cancer Center
http://www.som.tulane.edu/cancer or http://www.canceriscurable.com
Box SL-68, 1430 Tulane Avenue
New Orleans, Louisiana 70122-2699
(504) 988-6060, fax (504) 988-6077



This page is http://www.som.tulane.edu/cancer/newsletterac0403.html
This page was last updated on

---

Return to the top of this page.
Return to the Tulane Cancer Center homepage.
Calendars Clinical Trials Faculty Links Location News

Search Site index